(Medical Xpress) -- Of the world’s leading causes of death, stroke ranks second – and occurring 8 out of 10 times is ischemic stroke: reduced blood supply to the brain creates a shortage of oxygen, glucose and other ...
BGN Technologies, the technology-transfer company of Ben-Gurion University of the Negev (BGU), announced that a research group led by Prof. Varda Shoshan-Barmatz of the BGU Department of Life Sciences and the National Institute ...
May 11, 2018
0
140
Developmental biologist Eric Lai, Ph.D., and his lab at Memorial Sloan Kettering Cancer Center (MSK) have been studying hotbeds of biological conflict, except instead of battles between outside invaders and internal defenders, ...
Aug 28, 2023
0
80
The United States Patent and Trademark Office has reaffirmed the validity of four important patents in the field of RNA therapeutics.
Dec 12, 2011
0
0
According to new research by University of Kentucky investigators, an emerging pharmaceutical platform used in treating a variety of diseases may produce unintended and undesirable effects on eye function. The paper, "Short-interfering ...
Oct 11, 2011
0
0
In a new study published in Brain Prof. Xi Chen from Nanjing University and Prof. Zhong Pei from Sun Yat-sen University report the therapeutic reversal of Huntington's disease by in vivo self-assembled siRNAs.
Dec 22, 2021
0
44
Researchers at Albert Einstein College of Medicine have developed a topical drug that regenerates and restores the function of erectile nerves damaged by radical prostatectomy, the most common treatment for localized prostate ...
Apr 19, 2021
0
12
In recent years, RNA molecules, with the ability to affect or turn off pathogenic genes, have become promising drug candidates in several areas. However, it has been a challenge to develop techniques to deliver the RNA molecules ...
Apr 14, 2020
0
59
Society learned about the value of mRNA during the COVID-19 pandemic when we saw scientists and medical professionals harness its power to deliver a vaccine for the virus within a year.
Feb 20, 2024
0
15
A single dose of the small interfering ribonucleic acid (siRNA) drug candidate ALN-PCS cut levels of LDL cholesterol (bad cholesterol) in healthy volunteers by up to 57%, and 40% on average more than those given a placebo, ...
Oct 2, 2013
0
0
